Learn how to reduce your clinical study budget by 45-55% in Central and Eastern Europe by downloading this Whitepaper by Research Professionals CRO. This whitepaper identifies the most significant cost elements of a typical clinical study budget and breaks it… Read More
Download this Whitepaper by Research Professionals CRO to learn how to reduce your clinical study budget by 45-55% in Central and Eastern Europe. This whitepaper identifies the most significant cost elements of a typical clinical study budget and breaks it down line by line so you can maximise your… Read More
Domainex has opened a new lab facility at Unity Campus in Sawston, Cambridge. The company will be joining an existing community of biomedical companies at Unity Campus, including IONTAS, PhoreMost, Sareum and Liminal BioSciences. Official comments Dr Tom Mander, CEO of Domainex, said: “On… Read More
A new app note, brought to you by BellBrook Labs and supported by DDW, is available to download for free here. Clinical trials continue to determine whether therapeutic modulation of kinases can be used to suppress the immune system in autoimmune diseases or stimulate for… Read More
A new study by Qatar Foundation researchers from the Qatar Genome Research Consortium and Weill Cornell Medicine-Qatar has reported the first landscape of cancer germline variation – known as inherited cancer – in the Middle East. The study The study, led by Dr. Lotfi Chouchane… Read More
The startup company Novel Concepts Medical has announced breakthroughs in its research of Covid-19, which include stopping Covid-19, the Omicron Variant, and long Covid-19 symptoms, including memory loss. The treatment Its novel plant-based treatment has resulted in successfully inhibiting the Covid-19 Omicron variant and blocking… Read More
In this white paper, brought to you by BioRad, hear from leading industry experts in the emerging field of cancer vaccines. The experts discuss: Challenges related to antigen and adjuvant selection Vaccine design Immune response improvement Future treatment options Download the white paper here. Read More
Download the white paper to hear from leading industry experts in this emerging field who discuss: Challenges related to antigen and adjuvant selection Vaccine design Immune response improvement Future treatment options… Read More
Drug approvals are critical to the drug discovery industry, ensuring innovation thrives while the public remain safe from the risks and benefits associated with new drugs. Organisations responsible for these approvals include the US Food and Drug Administration (FDA), the European Medical Agency (EMA), the Scottish Medicines Consortium (SMC),… Read More
In January 2022, European Clinical Research Alliance for Infectious Diseases (Ecraid) became a legal entity and is now fully operational to advance knowledge in the field of infectious diseases. This is Ecraid’s initial step as it evolves into a self-sustaining, not-for-profit organisation conducting clinical research for both public and… Read More
The US Food and Drug Administration (FDA) has cleared investigational new drug (IND) applications for MRx0005 and MRx0029, two 4D Pharma Live Biotherapeutics (LBPs). The company expects to initiate a first-in-human Phase I clinical trial in people with Parkinson’s disease in mid-2022. Context Parkinson’s disease… Read More
More than half of all scientific research is irreproducible, and more than 80% of scientific research data is being lost within 20 years. In the biomedical field alone, irreproducible research costs the industry £28 billion (US$38 billion) every year. Megan Thomas talks to Founder of Labstep Jake Schofield, about this issue. MT:… Read More
The advanced therapy medicinal products (ATMPs) sector holds great promise. However, multidisciplinary strategies that begin early in the development process should be adopted, says Christian Schneider, head of Biopharma Excellence and Chief Medical Officer at PharmaLex. He outlines five strategies for avoiding pitfalls and boosting the success rates of development… Read More
News round-up by DDW’s Megan Thomas for 21-25 February, 2022 This week’s drug discovery news reflects breakthroughs across therapeutic areas with a focus on collaboration not just between scientists and institutions, but also businesses and regulatory organisations. 1. New human beta cell model enables discoveries in… Read More
The latest episode of the free DDW podcast is titled “A comprehensive analysis of European biotech”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas. The articles are “Innovation and opportunity within Europe’s… Read More
The latest episode of the free narrated DDW podcast is titled “A comprehensive analysis of European biotech”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas. The articles are “Innovation and opportunity within… Read More
